Sana Biotechnology's cash burn versus its market cap is worr...
Sana Biotechnology's cash burn versus its market cap is worrisome. Despite a notable decrease in its cash burn, the potential need for more funding via new shares could result in costly shareholder dilution.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000245dfe0ca97768.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment